Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Other Accumulated Expenses (2016 - 2026)

Dexcom has reported Other Accumulated Expenses over the past 16 years, most recently at $7.6 million for Q1 2026.

  • Quarterly Other Accumulated Expenses fell 84.89% to $7.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $7.6 million through Mar 2026, down 84.89% year-over-year, with the annual reading at $7.7 million for FY2025, 79.25% down from the prior year.
  • Other Accumulated Expenses was $7.6 million for Q1 2026 at Dexcom, down from $7.7 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $62.9 million in Q1 2022 and troughed at $7.6 million in Q1 2026.
  • The 5-year median for Other Accumulated Expenses is $42.0 million (2025), against an average of $40.5 million.
  • Year-over-year, Other Accumulated Expenses skyrocketed 41.67% in 2022 and then crashed 84.89% in 2026.
  • A 5-year view of Other Accumulated Expenses shows it stood at $39.7 million in 2022, then grew by 2.02% to $40.5 million in 2023, then dropped by 8.4% to $37.1 million in 2024, then plummeted by 79.25% to $7.7 million in 2025, then dropped by 1.3% to $7.6 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Other Accumulated Expenses are $7.6 million (Q1 2026), $7.7 million (Q4 2025), and $42.0 million (Q3 2025).